Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8443576 | European Journal of Cancer | 2014 | 8 Pages |
Abstract
Patients may be advised to forgo cALND where the SLN contains isolated tumour cells or micrometastasis. Recommendations for proceeding to cALND can be based on the size of metastasis in the SLN, which relates to the risk of further disease in the residual axillary lymph nodes and subsequent regional recurrence.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
A. Suyoi, S.K. Bains, A. Kothari, M. Douek, O. Agbaje, H. Hamed, I. Fentiman, S. Pinder, A.D. Purushotham,